| Autor: |
Ezenwa MO; 2 University of Florida, Gainesville, FL, USA., Suarez ML; 1 University of Illinois at Chicago, IL, USA., Carrasco JD; 1 University of Illinois at Chicago, IL, USA., Hipp T; 3 JourneyCare, Glenview, IL, USA., Gill A; 4 Rainbow Hospice and Palliative Care, Mount Prospect, IL, USA., Miller J; 3 JourneyCare, Glenview, IL, USA., Shea R; 4 Rainbow Hospice and Palliative Care, Mount Prospect, IL, USA., Shuey D; 1 University of Illinois at Chicago, IL, USA., Zhao Z; 1 University of Illinois at Chicago, IL, USA., Angulo V; 1 University of Illinois at Chicago, IL, USA., McCurry T; 4 Rainbow Hospice and Palliative Care, Mount Prospect, IL, USA., Martin J; 3 JourneyCare, Glenview, IL, USA., Yao Y; 2 University of Florida, Gainesville, FL, USA., Molokie RE; 1 University of Illinois at Chicago, IL, USA., Wang ZJ; 1 University of Illinois at Chicago, IL, USA., Wilkie DJ; 2 University of Florida, Gainesville, FL, USA. |
| Abstrakt: |
This purpose of this article is to describe how we adhere to the Patient-Centered Outcomes Research Institute's (PCORI) methodology standards relevant to the design and implementation of our PCORI-funded study, the PAIN RelieveIt Trial. We present details of the PAIN RelieveIt Trial organized by the PCORI methodology standards and components that are relevant to our study. The PAIN RelieveIt Trial adheres to four PCORI standards and 21 subsumed components. The four standards include standards for formulating research questions, standards associated with patient centeredness, standards for data integrity and rigorous analyses, and standards for preventing and handling missing data. In the past 24 months, we screened 2,837 cancer patients and their caregivers; 874 dyads were eligible; 223.5 dyads consented and provided baseline data. Only 55 patients were lost to follow-up-a 25% attrition rate. The design and implementation of the PAIN RelieveIt Trial adhered to PCORI's methodology standards for research rigor. |
